ArticleNursing open2025
Haemoglobin for Fall Risk Screening in Gynaecological and Obstetric Wards: Retrospective Survey and Delphi Validation.
Article in Nursing open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
aimsThe objective of this study is to ascertain the suitability of haemoglobin as a screening factor for falls among obstetrics and gynaecology inpatients and to formulate a stratified scheme for assessing fall risk based on haemoglobin.
designA retrospective analysis and Delphi surveys were employed for this investigation.
methodsInitially, a retrospective survey analysed falls among obstetrics and gynaecology inpatients in two hospitals from January 1, 2020, to July 10, 2022. Descriptive statistics, receiver operating characteristic (ROC) curve analysis, Youden index, sensitivity and specificity were utilised for data examination. The conclusions drawn were subsequently validated by Delphi surveys, featuring 21 experts participating in five rounds of consultation. The Kappa value and the coefficient of variation (CV) were employed to assess expert advice.
resultsThe area under the Receiver Operating Characteristic curve (AUC) of haemoglobin was 0.762 ± 0.030, 95% CI (0.703, 0.821). The highest Youden index was 0.425, with sensitivity at 0.705 and specificity at 0.720 when haemoglobin was 107.5 g/L. Two consensuses were reached by experts: anaemia was important in causing falls in obstetrics and gynaecology wards, and haemoglobin should be employed as a screening factor for falls. The stratification of anaemia was developed as follows: ≥ 110; 90-109; 60-89; and < 60 g/L. Approval for the final results was unanimous among all experts. The Kappa value (K*) was 1, and the CV of expert advice ranged from 0.092 to 0.219.
conclusionsHaemoglobin could potentially be used as a predictor of fall risk in Gynaecological and Obstetric Wards. The recommended stratified scheme for anaemia in fall risk assessment is as follows: ≥ 110; 90-109; 60-89; and < 60 g/L. IMPLICATIONS FOR THE PROFESSION AND/OR PATIENT CARE: What problem did the study address? The study revealed a relationship between falls and haemoglobin in obstetrics and gynaecology inpatients. It also proposed a stratification scheme for assessing fall risk based on haemoglobin levels. What were the main findings? Haemoglobin has a good performance on fall risk prediction in Gynaecological and Obstetric Wards. The stratified scheme of anaemia for fall risk assessment was suggested as follows: ≥ 110; 90-109; 60-89; and < 60 g/L. Where and on whom will the research have an impact? Nurses and inpatients in obstetrics and gynaecology wards will be affected by the results of this study, and it provided a reference for fall prevention. REPORTING
methodThis study has adhered to relevant EQUATOR guidelines and named the reporting method. No Patient or Public Contribution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.